The best logos are those that have truly stood the ... It's not a city that imposes its vision on people who come in; they ...

Vertex's focus for now is on being less of “a one-franchise organisation” and diversifying its portfolio. The company is investigating new medicines for serious diseases with key unmet needs.

KING OF PRUSSIA, Pa., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced that ...

HOUSTON (AP) — Vertex Energy Inc. VTNR) on Thursday reported a loss of $53.8 million in its second quarter. The Houston-based company said it had a loss of 58 cents per share. HOUSTON ...

Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

The VERTEX 80 and the VERTEX 80v vacuum FT-IR spectrometers from Bruker are based on the actively aligned UltraScan ™ interferometer, which provides PEAK spectral resolution. The precise linear ...

There are two main ways to work with Gemini Pro: Google AI Studio and Vertex AI on Google Cloud ... there is a dedicated Gemini Pro Vision endpoint that also accepts images along with text ...

Through our unparalleled collections and research capabilities, and the insight and creativity we foster through art, history, and culture, the Smithsonian strives to provide Americans and the world ...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...

KING OF PRUSSIA, Pa., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, has been announced at Oracle ...

Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.79% higher to $477.90 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 ...

Vertex Pharmaceuticals was founded in 1989 and operates in Boston, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100). This ...